Table 4.
TLE outcomes in different implant duration groups.
| TLE Outcomes | Leads under 10 Years | Leads 10–20 Years | Leads 20–30 Years | Leads over 30 Years | Statistic | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of patients/group number | 2524 | 1 | 926 | 2 | 190 | 3 | 33 | 4 | 2 vs. 1 | 3 vs. 1 | 4 vs. 1 |
| Form of results presentation | Count/aver. | %/Sd | Count/aver. | %/Sd | Count/aver. | %/Sd | Count/aver. | %/Sd | |||
| TLE efficacy and complications | |||||||||||
| Major complications | 15 | 0.59% | 37 | 4.00% | 16 | 8.42% | 6 | 18.18% | p < 0.001 | p < 0.001 | p < 0.001 |
| Haemopericardium | 7 | 0.28% | 24 | 2.59% | 13 | 6.84% | 4 | 12.12% | p < 0.001 | p < 0.001 | p < 0.001 |
| Haemothorax | 2 | 0.08% | 3 | 0.32% | 0 | 0.00% | 0 | 0.00% | 0.124 | 1.000 | 1.000 |
| Tricuspid valve damage during TLE (severe) | 4 | 0.16% | 10 | 1.08% | 4 | 2.11% | 2 | 6.06% | 0.001 | 0.001 | 0.002 |
| Rescue cardiac surgery | 9 | 0.36% | 22 | 2.38% | 11 | 5.59% | 3 | 9.09% | p < 0.001 | p < 0.001 | p < 0.001 |
| Death procedure related (intra. post-procedural) | 2 | 0.08% | 4 | 0.43% | 0 | 0.00% | 0 | 0.00% | 0.048 | 1.000 | 1.000 |
| Death indication-related (intra. post-procedural | 1 | 0.04% | 2 | 0.22% | 1 | 0.53% | 0 | 0.00% | 0.177 | 0.135 | 1.000 |
| 30-ty daysmortality | 38 | 1.51% | 21 | 2.27% | 3 | 1.58% | 1 | 3.03% | 0.167 | 0.819 | 0.996 |
| Partial radiographic success | 46 | 1.82% | 71 | 7.67% | 21 | 11.05% | 8 | 24.24% | p < 0.001 | p < 0.001 | p < 0.001 |
| Full clinical success | 2503 | 99.17% | 882 | 95.25% | 180 | 94.74% | 30 | 90.91% | p < 0.001 | p < 0.001 | 0.003 |
| Full procedural success | 2469 | 97.82% | 840 | 90.71% | 165 | 86.84% | 27 | 81.82% | p < 0.001 | p < 0.001 | p < 0.001 |